FDA Study Of Botox Safety Deepens Allergan's Frown
By Erin Marie Daly · February 8, 2008, 12:00 AM EST
Still smarting from recent public scrutiny from a consumer advocacy group over Botox, Allergan Inc. has been hit with more bad news. The U.S. Food and Drug Administration announced Friday it...
To view the full article, register now.